1. Home
  2. RPTX vs GCV Comparison

RPTX vs GCV Comparison

Compare RPTX & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPTX
  • GCV
  • Stock Information
  • Founded
  • RPTX 2016
  • GCV 1988
  • Country
  • RPTX Canada
  • GCV United States
  • Employees
  • RPTX N/A
  • GCV N/A
  • Industry
  • RPTX Biotechnology: Pharmaceutical Preparations
  • GCV Finance/Investors Services
  • Sector
  • RPTX Health Care
  • GCV Finance
  • Exchange
  • RPTX Nasdaq
  • GCV Nasdaq
  • Market Cap
  • RPTX 63.9M
  • GCV 76.3M
  • IPO Year
  • RPTX 2020
  • GCV N/A
  • Fundamental
  • Price
  • RPTX $1.41
  • GCV $3.80
  • Analyst Decision
  • RPTX Strong Buy
  • GCV
  • Analyst Count
  • RPTX 3
  • GCV 0
  • Target Price
  • RPTX $4.50
  • GCV N/A
  • AVG Volume (30 Days)
  • RPTX 92.3K
  • GCV 57.9K
  • Earning Date
  • RPTX 08-05-2025
  • GCV 01-01-0001
  • Dividend Yield
  • RPTX N/A
  • GCV 13.04%
  • EPS Growth
  • RPTX N/A
  • GCV N/A
  • EPS
  • RPTX N/A
  • GCV N/A
  • Revenue
  • RPTX $1,073,000.00
  • GCV N/A
  • Revenue This Year
  • RPTX N/A
  • GCV N/A
  • Revenue Next Year
  • RPTX N/A
  • GCV N/A
  • P/E Ratio
  • RPTX N/A
  • GCV N/A
  • Revenue Growth
  • RPTX N/A
  • GCV N/A
  • 52 Week Low
  • RPTX $0.89
  • GCV $3.15
  • 52 Week High
  • RPTX $4.29
  • GCV $4.58
  • Technical
  • Relative Strength Index (RSI)
  • RPTX 51.83
  • GCV 59.07
  • Support Level
  • RPTX $1.33
  • GCV $3.66
  • Resistance Level
  • RPTX $1.48
  • GCV $3.75
  • Average True Range (ATR)
  • RPTX 0.05
  • GCV 0.05
  • MACD
  • RPTX -0.01
  • GCV -0.01
  • Stochastic Oscillator
  • RPTX 34.37
  • GCV 71.05

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

About GCV Gabelli Convertible and Income Securities Fund Inc. (The)

GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.

Share on Social Networks: